Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab, Abbott Gmbh & Co KgfiledCriticalAbbott Lab
Publication of DOP2009000085ApublicationCriticalpatent/DOP2009000085A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un compuesto heterocíclico de fórmula general (1) y su uso y su preparación, métodos para preparlo, composiciones que contienen al menos uno de dichos compuestos, y métodos de tratamiento donde se usa al menos un compuesto. En particular, los compuestos de fórmulas general (1) son útiles para inhibir la glucógeno sintetasa quinasa 3 (GSK-3).A heterocyclic compound of the general formula (1) and its use and its preparation, methods for preparing it, compositions containing at least one of said compounds, and treatment methods where at least one compound is used. In particular, the compounds of general formulas (1) are useful for inhibiting glycogen synthase kinase 3 (GSK-3).
DO2009000085A2006-10-212009-04-21
HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF GLUCOGEN
DOP2009000085A
(en)